Should You Bank These 3 Winners?

Published in Investing on 16 August 2012

Is it time to sell Associated British Food (LSE: ABF), Rolls-Royce (LSE: RR.) or Unilever (LSE: ULVR)?

If you're reading this, you probably own one or more of the following three shares:

Their common feature? They're all blue chips with share prices flirting with all-time highs.

Here are the details compared to the FTSE 100 (UKX).

 All-time highRecent priceGain required to reach all-time high
Ass Brit Food1,295p1,294p<0.1%
Rolls-Royce890p861p3%
Unilever2,334p2,274p3%
FTSE 1006,9305,81319%

I'm sure long-term shareholders of all three companies will be chuffed with their gains right now. But as always with shares, prices can race ahead of reality and sometimes it can pay to bank your winners while the going is good.

Let's have a quick look at the trio to see if any profits need to be taken:

Associated British Food

The sugar and retail conglomerate has enjoyed a good recession, with sales up 63% and adjusted operating profits up 48% between 2007 and 2011.

Progress during 2012 has been encouraging, too, with strong sugar prices and good sales at Primark helping year-to-date revenues advance 11%. The performance has prompted ABF to expect "substantial growth" in profits for the current year.

Brokers translate this optimism into earnings of 87p per share, up 18% on 2011, which equates to a price-to-earnings (P/E) ratio of 15. In comparison, statistics on Bloomberg indicate ABF's forecast P/E reaching a five-year high of 17.5 during 2007.

Although the ABF's current P/E rating is towards the top end of its range, the firm's upbeat comments suggest to me the share price could be justified.

Rolls-Royce

The aerospace group has performed well during the downturn, with sales up 50% and adjusted earnings per share up 43% between 2007 and 2011.

Progress during 2012 has been positive, too, with further sales of Trent engines helping first-half earnings per share advance 11%. The performance prompted Rolls to expect "good growth" in underlying revenue and profit for the current year.

Brokers translate this confidence into earnings of 58p per share, up 19% on 2011, which equates to a P/E of 15. For perspective, statistics on Bloomberg indicate Rolls' forecast P/E reaching a five-year high of almost 16 during 2011.

Similar to ABF, although the Rolls' current P/E rating is towards the top end of its range, the firm's upbeat comments suggest to me the share price could be justified.

Unilever

The consumer-goods powerhouse continued to progress during the banking crash, with sales up 16% and pre-tax profits up 18% between 2007 and 2011.

This year's efforts have been pleasing, too, with greater sales to emerging markets supporting a 4% profit gain during the first half. The achievement prompted Unilever to expect a "modest improvement" in its core operating margin for the full year.

Brokers translate this confidence into earnings of about €1.56 per share, up 10% on 2011, which equates to a P/E of 19. In comparison, statistics on Bloomberg indicate Unilever's forecast P/E reaching a five-year high of nearly 20 during 2007.

With Unilever's current P/E rating at top end of its range, I'm not 100% convinced the firm's progress this year justifies the share price. If I were a holder, I think I might bank some profits.

More all-time highs

One long-term investor whose shares have also done well of late is Neil Woodford, the head of investments at Invesco Perpetual and one of the smartest blue-chip investors in the City.

In fact, on a dividend re-invested basis over the 15 years to 31 December 2011, Mr Woodford has delivered a return of 347%, versus the FTSE All-Share's distinctly more modest 42% performance.

Helping drive that performance has been a substantial position in British American Tobacco (LSE: BATS), which has been hitting fresh all-time highs throughout 2012.

Mr Woodford's other favourite holdings -- and the investing logic behind them -- are profiled in "8 Large-Cap Income Shares Held By Britain's Super Investor", a special report that is exclusive to The Motley Fool.

This report is free and can be delivered to your inbox in seconds. However, all Fool reports are available for a limited time only.

Baffled by shares? This special report -- "What Every New Investor Needs To Know" -- can start you on the path to investing. What's more, the report is free!

Further Motley Fool investment opportunities:

> Maynard does not own any of the shares mentioned in this article.

Share & subscribe

Comments

The opinions expressed here are those of the individual writers and are not representative of The Motley Fool. If you spot any comments that are unsuitable hit the flag to alert our moderators.

goodlifer 16 Aug 2012 , 3:20pm

Woodford?
Haven't I heard that name before?

IDPickering 16 Aug 2012 , 4:55pm

I hold Unilever in both my HYPs, and have no intention of selling out.

Let the winners ride.

QuantumDealer 16 Aug 2012 , 6:04pm

I am a holder of RR. and ULVR and intend to hold both too. If both keep producing decent numbers then the rating is easily justified and can continue on an upward trajectory given that the market will attach a premium to consistency and business growth.

ANuvver 16 Aug 2012 , 8:42pm

For me, banking the profits involves having a good home in mind for the proceeds or a willingness to keep money out of the game for a while. For we "Death or Value Toads" hereabouts, I think pickings are slim right now.

That's not to say that the institutional sharks that we pilot around are not capable of mounting sporadic sorties out of bills - which of course represents them banking profits and turning the Eye of Sauron onto a justifiable risk trade in lower-beta equities.

Hmm. Seem to have gone from Wind in the Willows, via Jaws, to LOTR in one post there - sorry about that.

My interest is ULVR. Frankly, it has everything I want - solid books, sound brands, international spread and a committed and sustainable dividend policy. I'm not selling. My fighting fund is fine as it is.

I'm with Quantum on steady becoming the new exciting. AFAICS some of the recent US action has involved some leakage from Treasuries into commodities and cyclicals, but the big, blue boringers (damnit, now I've done Dr Who as well) are still getting their fair share of the flows.

I'm also with Pickering on running winners, particularly in this investment region. One buys this kind of share to do a job, year in year out. If my investment premise hasn't changed, the "screen profit" doesn't really matter much to me. Of course, it's nice to see!

goodlifer 16 Aug 2012 , 10:12pm

I don't hold any of these at present.

FWIW, if I did I'd be inclined to hang on to ULVr, don't ask me why..

I'd seriously consider selling the other two, but only if I could find something worth buying with the proceeds.
I'd be in no hurry.

paulgmoody 17 Aug 2012 , 9:57am

I agree with QuantumDealer as well. I hold ABF and ULVR and will continue to do so unless some future event(s) happens to them that would cause me to re-evaluate them.

ANuvver - liked the Eye of Sauron association with the institutional sharks :-)

richjfool 17 Aug 2012 , 12:57pm

As a holder of ABF and ULVR I agree with the above & wouldn't want to be selling.

Alan Oscroft even seems to favour buying Unilever even though not cheap:

http://www.fool.co.uk/news/investing/2012/08/16/beginners-portfolio-we-buy-a-miner.aspx

I don't know who this Woodford bloke is, but don't think he holds any of those 3 stocks in his top ten holdings anyway. Eat your heart out Woody.

yossa123 17 Aug 2012 , 2:41pm

Hi Mayny,

Unilever is still a hold from James Early (looking after the old D.E recs).

Join the conversation

Please take note - some tags have changed.

Line breaks are converted automatically.

You may use the following tags in your post: [b]bolded text[/b], [i]italicised text[/i]. All other tags will be removed from your post.

If you want to add a link, please ensure you type it as http://www.fool.co.uk as opposed to www.fool.co.uk.

Hello stranger

To add your own comment, please login.

Not yet registered? Register now.